Kelman-Lazarov, Inc. - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 172 filers reported holding ANTARES PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Kelman-Lazarov, Inc. ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2021$62,000
+3.3%
15,0000.0%0.02%
-4.3%
Q4 2020$60,000
+46.3%
15,0000.0%0.02%
+21.1%
Q3 2020$41,0000.0%15,0000.0%0.02%0.0%
Q2 2020$41,00015,0000.02%
Other shareholders
ANTARES PHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 3,096,355$8,422,0005.18%
JW Asset Management, LLC 1,920,524$5,224,0003.85%
Healthcare Value Capital, LLC 250,000$680,0002.64%
ARMISTICE CAPITAL, LLC 10,300,000$28,016,0002.12%
Broadfin Capital, LLC 3,444,147$9,368,0001.23%
PERKINS CAPITAL MANAGEMENT INC 409,000$1,112,0000.86%
MYCIO WEALTH PARTNERS, LLC 1,896,500$5,158,0000.48%
ESSEX INVESTMENT MANAGEMENT CO LLC 1,012,600$2,754,0000.22%
FALCON POINT CAPITAL, LLC 130,200$354,0000.21%
Brown Advisory Securities, LLC 275,000$781,0000.15%
View complete list of ANTARES PHARMA INC shareholders